Lung Biopsy Systems Market Players:
- Argon Medical Devices, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Fujifilm Corporation
- Cardinal Health, Inc.
- DTR Medical Ltd
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Olympus Corporation
- Hologic Inc.
- Medtronic Limited
- Zimmer Biomet Holdings, Inc
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of lung biopsy systems is evaluated at USD 5.72 billion.
The global lung biopsy systems market size was worth over USD 5.03 billion in 2025 and is poised to grow at a CAGR of around 15.3%, reaching USD 20.89 billion revenue by 2035.
North America is set to command a 42% share of the Lung Biopsy Systems Market by 2035, propelled by the growing volume of research and clinical trials focused on new lung cancer treatment approaches.
Key players in the market include Argon Medical Devices, Inc., Fujifilm Corporation, Cardinal Health, Inc., DTR Medical Ltd, B. Braun Melsungen AG, Becton, Dickinson and Company, Olympus Corporation, Hologic Inc., Medtronic Limited, Zimmer Biomet Holdings, Inc.
